|
UBE4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.82759999999682E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36710000000029E-05 |
| Normal-vs-Stage2 |
6.048100E-02 |
| Normal-vs-Stage3 |
1.219130E-03 |
| Normal-vs-Stage4 |
9.818800E-03 |
| Stage1-vs-Stage2 |
6.504800E-01 |
| Stage1-vs-Stage3 |
4.023400E-01 |
| Stage1-vs-Stage4 |
9.825000E-01 |
| Stage2-vs-Stage3 |
3.751200E-01 |
| Stage2-vs-Stage4 |
7.880800E-01 |
| Stage3-vs-Stage4 |
6.170400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.016550E-04 |
| Normal-vs-AfricanAmerican |
2.955100E-04 |
| Normal-vs-Asian |
2.730800E-01 |
| Caucasian-vs-AfricanAmerican |
5.754800E-01 |
| Caucasian-vs-Asian |
9.111600E-01 |
| AfricanAmerican-vs-Asian |
9.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87159999998077E-06 |
| Normal-vs-Female |
1.597970E-01 |
| Male-vs-Female |
1.103990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.673600E-02 |
| Normal-vs-Extreme_Weight |
3.78960000047002E-07 |
| Normal-vs-Obese |
3.197600E-04 |
| Normal-vs-Extreme_Obese |
3.122100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.858100E-02 |
| Normal_Weight-vs-Obese |
4.465200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.801200E-01 |
| Extreme_Weight-vs-Obese |
2.407400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.952400E-01 |
| Obese-vs-Extreme_Obese |
5.735800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.313200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.006000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.20829999999506E-05 |
| Normal-vs-Age(81-100Yrs) |
8.433300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.829600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.101200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.234400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.417000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.230800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.002200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.359700E-04 |
| Normal-VS-Type2 PRCC |
5.6940999999977E-05 |
| Normal-VS-KIRP CIMP |
2.042200E-03 |
| Normal-VS-Unclassified PRCC |
7.690400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.004000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.609400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.688500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.103800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.082160E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.142410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.202300E-04 |
| Normal-vs-N1 |
3.414800E-04 |
| Normal-vs-N2 |
8.634000E-02 |
| N0-vs-N1 |
8.148600E-01 |
| N0-vs-N2 |
8.343400E-01 |
| N1-vs-N2 |
7.101800E-01 |
|
|
